17851-46-6

Upstream product

• 103632-91-3 2-[2-(methoxycarbonyl)ethyl]-2-phenyl-1,3-dioxolane 
• 2051-95-8 succinylbenzene 
• 6270-17-3 ethyl 3-benzoylpropanoate 
• 17851-55-7 2-(2-ethoxycarbonylethyl)-2-phenyl-1,3-dioxolane 

Downstream Products

• 139518-46-0 2-(3-Acetoxypropyl)-2-phenyl-1,3-dioxolane 
• 139518-42-6 2-(3-Benzyloxypropyl)-2-phenyl-1,3-dioxolane 
• 70969-99-2 1,1-Ethylenedioxy-4-iodo-1-phenylbutane 
• 139518-30-2 4-Benzyloxy-1-acetoxy-1-phenylbutane 
• 139518-36-8 4-Benzyloxy-2-oxo-1-methoxy-1-phenylbutane 
• 139518-44-8 4-Benzyloxy-2-bromo-1-oxo-1-phenylbutane 
• 139518-43-7 4-(benzyloxy)-1-phenylbutan-1-one 
• 139518-33-5 4-(benzyloxy)-1-phenylbutan-1-ol 
• 139518-45-9 4-Oxo-4-phenyl-3-bromo-1-acetoxybutane 
• 139518-39-1 4-Benzyloxy-2-oxo-1-phenylbutane 
• 105632-42-6 4-Phenyl-3,4-epoxy-1-butanol 
• 39755-06-1 4-Oxo-4-phenyl-1-acetoxybutane 

Relevant academic research and scientific papers

Dehydrogenation of perfluoroalkyl ketones by using a recyclable oxoammonium salt

A novel dehydrogenation reaction of perfluoroalkyl ketones by the oxoammonium salt 4-acetylamino-2,2,6,6-tetramethylpiperidine-1-oxoammonium tetrafluoroborate (4-NHAc-TEMPO+BF4-, Bobbitt's salt, 1) is described. The reaction proceeds under mildly basic conditions and appears to be unique to perfluoroalkyl ketones. A proposed mechanism for this unusual transformation is given. The byproduct of the reaction, 4-acetylamino-2,2,6,6-tetramethyl-1-piperidinyloxy (1a), can easily be recovered and used to regenerate the oxoammonium salt. The dehydrogenation of perfluoroalkyl ketones by using an oxoammonium salt is reported. The reaction proceeds under mildly basic conditions and affords α,β-unsaturated products in fair to excellent yields. The reaction likely proceeds through a two-step sequence. The spent oxidant can easily be recovered and used to regenerate the oxoammonium salt. Copyright

Studies on non-thiazolidinedione antidiabetic Agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents

We previously reported that (Z)-2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl) methoxy]benzyloxyimino}-2-(4-phenoxyphenyl)acetic acid (3) showed potent glucose and lipid lowering effects in genetically obese and diabetic mice, KKA y. This compound a

Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity

This invention provides a novel oxyiminoalkanoic acid derivative which has excellent hypoglycemic and hypolipidemic actions and which is used for the treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance and impaired glucose tolerance.

The First Tandem [2 + 2] Cycloaddition-Michael Reaction Using Ynolates: Facile Construction of Substituted Carbocycles

(matrix presented) A tandem [2 + 2] cycloaddition-Michael reaction using ynolate anions followed by decarboxylation produced polysubstituted five-, six-, and seven-membered cycloalkenes.

Elevation of HDL cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates

This invention relates to the treatment of atherosclerosis via raising the level of HDL cholesterol by administration of a compound of the formula STR1 wherein R1, R2, and R3 are independently hydrogen, C1 -Csu

Dipeptides as renin inhibitors

Dipeptides are described which are represented by the formula STR1 wherein the various substituents are defined hereinbelow. These compounds have a strong inhibitory efect on human renin, and are useful as a therapeutically active agent for the treatment of hypertension, especially renin-associated hypertension.